Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-15-061770

Chief Executive Officer sold 5,200 shares at an average $60.71 ($315,680)

From the SEC's structured data for this filing

Trades in this filing

Ciechanover Isaac E. · Chief Executive Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2015-07-16 Sale : show line 1 in the form −1,710 $60.90 $104,139 388,872 I
2015-07-16 Sale : show line 2 in the form −690 $61.70 $42,573 388,182 I
2015-07-16 Sale : show line 3 in the form −200 $62.90 $12,580 387,982 I
2015-07-17 Sale : show line 4 in the form −1,800 $59.90 $107,820 386,182 I
2015-07-17 Sale : show line 5 in the form −800 $60.71 $48,568 385,382 I
Open-market sales · 5,200 sh · avg $60.71 · $315,680
Loading xslF345X03/doc4.xml…